NCT02395744View on ClinicalTrials.gov

The COPPER-B Trial

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

March 11, 2015

Primary Completion Date

August 15, 2016

Study Completion Date

February 23, 2017

Conditions
Cardiovascular DiseasesPeripheral Vascular DiseaseArterial Occlusive DiseasesPeripheral Arterial DiseaseCritical Limb Ischemia
Interventions
OTHER

Paclitaxel administration using the OPC

Trial Locations (4)

36532

Cardiology Associates, Fairhope

48124

Michigan Outpatient Vascular Institute, Dearborn

70361

Cardiovascular Institute of the South, Houma

75701

Cardiovascular Associates of East Texas, Tyler

Sponsors
All Listed Sponsors
collaborator

Advanced Catheter Therapies, Inc.

INDUSTRY

lead

Horizons International Peripheral Group

OTHER

NCT02395744 - The COPPER-B Trial | Biotech Hunter | Biotech Hunter